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Besides genes that are homologous to proteins found in other coronaviruses, the severe acute respiratory
syndrome coronavirus genome also contains nine other potential open reading frames. Previously, we have
characterized the expression and cellular localization of two of these “accessory” viral proteins, 3a (previously
termed U274) and 7a (previously termed U122). In this study, we further examined whether they can induce
apoptosis, which has been observed clinically. We showed that the overexpression of 7a, but not of 3a or the
viral structural proteins, nucleocapsid, membrane, and envelope, induces apoptosis. 7a induces apoptosis via
a caspase-dependent pathway and in cell lines derived from different organs, including lung, kidney, and liver.
A novel coronavirus was identified as the etiological agent of
severe acute respiratory syndrome (SARS) (8, 12, 16, 24). The
SARS coronavirus (SARS-CoV) genome is 30 kb in length
and contains 14 potential open reading frames (ORFs). These
contain the replicase gene 1a/1b and correspond to the four
structural proteins (spike [S], envelope [E], membrane [M],
and nucleocapsid [N]), as well as nine viral proteins, varying in
length from 39 to 274 amino acids, with no homologue in other
coronaviruses (19, 25, 29). Recently, we showed that two of
these proteins, termed U274 and U122, are expressed in
SARS-CoV-infected cells (11, 28). U274 (also known as
ORF3, X1, or ORF3a (19, 25, 29), is encoded by the first ORF
of subgenomic RNA3, is expressed on the surface of infected
cells, and undergoes endocytosis (28). U122 (also known as
ORF8, X4, or ORF7a [19, 25, 29]) is encoded by the first ORF
of subgenomic RNA7 and contains a signal peptide at the N
terminus and a typical endoplasmic reticulum retrieval motif,
KRKTE, at the C terminus (11). Since the nomenclature used
by Thiel and colleagues (29) is more consistent with those used
for other coronaviruses, we shall refer to U274 and U122 as 3a
and 7a, respectively, in this paper.
Based on studies with other coronaviruses, it may be pre-
dicted that these group-specific proteins are dispensable for
viral replication, at least in a cell culture system, but may be
important for virus-host interactions and thus contribute to
viral fitness (for reviews, see references 5 and 17). Many virus
genomes encode gene products that can modulate apoptosis
(for a review, see references 2–4, 10, 14, 26, and 30). Induction
of apoptosis in infected cells can contribute directly to viral
pathogenesis, while inhibition of apoptosis can prevent prema-
ture death of the infected cells, allowing the virus to replicate
to a high titer or allowing the establishment of a persistent
infection. In the case of SARS-CoV, studies on the clinical
features of the disease have revealed some common abnormal-
ities, such as elevated lactate dehydrogenase, lymphopenia,
thrombocytopenia, hypocalcemia, and liver enzyme abnormal-
ities (for a review, see references 15, 21, 22, and 23). Besides
lymphopenia, which is caused by the depletion of T lympho-
cytes by apoptosis, one study also reported apoptosis in the
hepatocytes of three SARS patients who had liver impairment
(6). Apoptosis was also observed in Vero E6 cells infected by
SARS-CoV (31). Overall, these findings indicate that apopto-
sis plays an important role during SARS-CoV infection. In
order to determine if 3a and 7a play any role in the induction
of apoptosis during infection, we examine the ability of these
two SARS-CoV-specific proteins to induce apoptosis in cell
lines derived from different organs.
We first transfected 293T cells with cDNA constructs for
expressing the various SARS-CoV genes, using a lipofectamine
reagent (Invitrogen, Carlsbad, Calif.). These constructs were
obtained from SARS-CoV 2003VA2774, an isolate from a
SARS patient in Singapore (11, 27, 28). Two micrograms of
DNA was used to transfect 106 cells, and the cells were left for
approximately 16 h. When HA-tagged glutathione S-trans-
ferase protein (HA-GST) was expressed, it was observed that
the expression level of this protein was extremely high; there-
fore, 0.25 g of the plasmid for expressing HA-GST together
with 1.75 g of empty vector were used instead. The cells were
harvested and washed with phosphate-buffered saline and then
resuspended in 100 l of hypotonic cell lysis buffer. The
suspension of cells was divided into two aliquots, one to be
used for measuring caspase-3 protease activity and one for
Western blot analysis.
One aliquot was subjected to five rounds of freeze-thaw
cycles and then centrifuged to remove the cell debris. The total
protein concentration in the lysate was determined by using
Coomassie Plus reagent from Pierce (Rockford, Ill.). The
amount of caspase-3 protease activity in 10 g of total protein
was then determined by using the CaspACE fluorometric assay
system from Promega Corporation (Madison, Wis.). Lae-
mmli’s sodium dodecyl sulfate buffer was added to the other
aliquot, which was then heated at 100°C for 10 min, and then
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20 l of this total cell suspension was subjected to Western blot
analysis (11, 27, 28). For detection of endogenous poly(ADP-
ribose) polymerase (PARP) protein, a polyclonal antibody
(Cell Signaling Technology, Inc., Beverly, Mass.) that recog-
nizes full-length PARP (116 kDa) and the cleaved form of
PARP (83 kDa) was used.
The overexpression of HA-tagged 7a (7a-HA) induces apo-
ptosis in 293T (human kidney epithelial) cells, as evidenced by
an increase in caspase-3 protease activity, a hallmark of apo-
ptosis, which is comparable to that caused by the overexpres-
sion of BAX, a proapoptotic member of the Bcl-2 family (Fig.
1A, columns 1 and 3). Cleavage of endogenous PARP was also
observed when either 7a-HA or HA-BAX was overexpressed
(Fig. 1B, lanes 1 and 3). On the other hand, 3a-HA did not
significantly induce apoptosis; neither did the structural pro-
teins, M-HA, E-HA, and HA-N (Fig. 1A and B, lanes 4 to 7).
To determine the degree of cell death, cell viability was also
determined by using the cell proliferation reagent WST-1
(Roche Molecular Biochemicals, Indianapolis, Ind.). In this
case, 0.3  106 cells in a 24-well plate were transfected with
0.35 g of DNA and then assayed after 16 h, and the percent-
ages of live cells are shown in Fig. 1A in parentheses. Consis-
tent with the caspase assay, overexpression of 7a leads to cell
death, as evidenced by the decrease in cell viability to 44%
(Fig. 1A, column 3).
Apoptosis was also observed with the expression of either
the HA-tagged 7a or the untagged form of 7a and was medi-
ated via caspases, since it was strongly blocked by the pan-
FIG. 1. Expression of the viral proteins in 293T cells and the effects on apoptosis. (A) The CaspACE fluorometric assay system from Promega
Corporation was used to measure the activation of caspase-3 protease activity, which is a hallmark of apoptosis, in cells that were transfected with
a positive control (HA-BAX; column 1), a negative control (HA-GST; column 2), and the different SARS-CoV proteins (columns 3 to 7). All
experiments were performed in duplicate; the average values with standard deviations are plotted. For cell viability assays, experiments were
performed in triplicate, and the average percentages ( standard deviations) of live cells, compared to that for HA-GST, which is normalized to
100%, are shown in parentheses above each column. (B) Western blot analysis to determine the cleavage of endogenous full-length PARP, which
is a substrate of activated caspase-3, from 116 to 83 kDa (upper panel). Expression levels of the HA-tagged proteins were determined with anti-HA
antibody (middle panel), and the amounts of total cell lysates loaded were verified by measuring the level of endogenous actin (lower panel).
(C) The CaspACE fluorometric assay system from Promega Corporation was used to measure the activation of caspase-3 in cells that were
transfected with 7a-HA, 7a, or HA-BAX in the presence of a pan-caspase inhibitor, zVAD-fmk (columns 2 to 4) or an irrelevant peptide, zFA-fmk
(columns 5 to 7). (D) Western blot analysis were performed to determine the cleavage of endogenous PARP (upper panel), expression levels of
HA-GST, 7a-HA, 7a, and HA-BAX (anti-7a or anti-HA; middle panels), and endogenous actin as a loading control (antiactin; lower panel). Since
the anti-7a antibody was obtained by using a GST-fusion protein, it recognizes both the 7a and GST proteins.
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caspase inhibitor z-VAD-fmk (Fig. 1C and D, lanes 1 to 4). In
contrast, no inhibition of apoptosis was observed in the pres-
ence of an irrelevant peptide, z-FA-fmk (Fig. 1C, D, lanes 5 to
7). As reported previously (11), about 50% of the precursor
form of 7a (17.5 kDa) is cleaved after the signal peptide at
the N terminus, yielding a product of 15 kDa (Fig. 1D, lanes
3 and 6). However, the HA-tagged form of 7a does not appear
to undergo cleavage, since only a single band of 22 kDa,
which corresponds to an unprocessed form of 7a (17.5 kDa)
fused with three HA (YPYDVPDYA) motifs (4 kDa) at the
C terminus, is observed (Fig. 1D, lanes 2 and 5). It is yet
unknown why the HA tag at the C terminus of 7a affects its
processing, but our observations suggest that cleavage of the
signal peptide is not essential for the induction of apoptosis.
The experiment was repeated with cell lines derived from
different organs (Fig. 2): cervical (HeLa; human cervical car-
cinoma cells), lung (A549; human lung carcinoma cells), liver
(HepG2; human hepatocellular carcinoma cells), and kidney
(Vero E6 and COS-7; African green monkey kidney epithelial
and fibroblast cells, respectively). Increases in caspase-3 pro-
tease activities and PARP cleavage were observed when
7a-HA (Fig. 2, lanes 2, 5, 8, 11, and 14) or HA-BAX (Fig. 2,
lanes 3, 6, 9, 12, and 15) were overexpressed in all the cell lines
tested, in comparison to cells transfected with a control plas-
mid, HA-GST (Fig. 2, lanes 1, 4, 7, 10, and 13). This is con-
sistent with the findings that different organs infected by
SARS-CoV showed extensive apoptosis (6, 32). The signal
peptide at the N terminus of 7a is cleaved more efficiently in
infected cells than in transfected cells (11), but this cleavage is
not important for induction of apoptosis, since both mutants
7a-L, which contains mutations at the cleavage site (11), and
mat7a, where the signal peptide has been deleted (11), induce
the same degree of apoptosis as wild-type 7a (Fig. 3A). This
result is also consistent with the data shown in Fig. 1C and D,
where 7a and 7a-HA, where the signal peptide is not cleaved,
induce similar degrees of apoptosis.
The levels of caspase-3 protease activity in lysates obtained
from Vero E6 cells transfected with 7a cDNA (Fig. 3B, lanes 1
and 2) are significantly lower than that for SARS-CoV-infected
Vero E6 cells (Fig. 3B, lane 4), even though the expression
levels of 7a are comparable (Fig. 3B). These cells were infected
at a multiplicity of infection of 0.1 and harvested 24 h postin-
fection as previously described (28). This implies that 7a is not
the only apoptosis-inducing factor during SARS-CoV infection
in Vero E6 cells. This is not surprising, since coronaviruses are
known to cause cell-cell fusion during the late stages of infec-
tion, resulting in syncytium formation and cytopathic effects
(17). In future studies, it would be crucial to determine the
precise contribution of 7a to the cytopathic effects of SARS-
CoV infection, for example, by studying infectious clones with
FIG. 2. Induction of apoptosis by 7a in cell lines derived from different organs. The cell lines used were HeLa (cervical carcinoma) (lanes 1 to
3), HepG2 (liver carcinoma) (lanes 4 to 6), A549 (lung carcinoma) (lanes 7 to 9), and COS-7 and Vero E6 (kidney) (lanes 10 to 12 and 13 to 15,
respectively). All cell lines were purchased from the American Type Culture Collection (Manassas, Va.). The CaspACE fluorometric assay system
from Promega Corporation was used to measure the activation of caspase-3 protease in different cell lines that were transfected with HA-GST,
7a-HA, and HA-BAX (first panel). Western blot analysis were performed to determine the cleavage of endogenous PARP (second panel),
expression levels of HA-GST, 7a-HA, and HA-BAX (anti-HA) (third panel), and endogenous actin as a loading control (antiactin) (fourth panel).
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the 7a gene deleted or by determining if there is a correlation
between the expression of 7a and the degree of apoptosis in
clinical samples.
Induction of apoptosis has been observed during infection
by other coronaviruses, including mouse hepatitis virus (20),
feline infectious peritonitis virus (13), transmissible gastroen-
teritis coronavirus (9), and human coronavirus strain 229E (7).
In some cases, the overexpression of a single viral protein, such
FIG. 3. Induction of apoptosis by overexpression of wild-type 7a and 7a mutants (7a-L and mat7a) in A549 and Vero E6 cells and by
SARS-CoV infection of Vero E6 cells. (A) The CaspACE fluorometric assay system from Promega Corporation was used to measure the activation
of caspase-3 protease in different cell lines that were transfected with HA-GST (negative control) (lanes 1 and 5), wild-type 7a (lanes 2 and 6),
mutant 7a-L (lanes 3 and 7), and mutant mat7a (lanes 4 and 8) (first panel). 7a-L contains mutations at the signal peptide cleavage site and is
cleaved less efficiently than the wild type, and mat7a does not contain the signal peptide (see reference 11). Western blot analyses were performed
to determine the expression levels of the GST and 7a proteins (anti-7a; second panel) and endogenous actin as a loading control (antiactin; third
panel). (B) Caspase-3 protease activities in Vero E6 cells transfected with 1.0 g (lane 1) or 2.0 g (lane 2) of 7a plasmid or mock-infected cells
(lane 3) or SARS-CoV-infected cells (lane 4) were determined (first panel). Western blot analyses were performed to determine the expression
levels of 7a (anti-7a; second panel), SARS-CoV N (anti-N [12a]; third panel), and endogenous tubulin as a loading control (monoclonal antitubulin
[Sigma]; fourth panel) in 20 g of cell lysates.
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as the E protein of mouse hepatitis virus (1) or a 58-kDa
protein encoded in ORF 1b of infectious bronchitis virus (18),
was sufficient to induce apoptosis. Our data suggest that 7a of
SARS-CoV is another example of a coronavirus protein that
can induce apoptosis when overexpressed. Although 7a was
detected in SARS-CoV-infected Vero E6 cells (11), it is still
unknown at what level this protein is expressed in infected
organs. Nevertheless, the ability of 7a to induce apoptosis in
different cell types is consistent with the clinical observation of
apoptosis in different organs infected by SARS-CoV and sug-
gests that the expression of 7a during infection may be one of
the underlying mechanisms for the pathogenesis of SARS-CoV
infection.
REFERENCES
1. An, S., C. J. Chen, X. Yu, J. L. Leibowitz, and S. Makino. 1999. Induction of
apoptosis in murine coronavirus-infected cultured cells and demonstration
of E protein as an apoptosis inducer. J. Virol. 73:7853–7859.
2. Barber, G. N. 2001. Host defense, viruses and apoptosis. Cell Death Differ.
8:113–126.
3. Benedict, C. A., P. S. Norris, and C. F. Ware. 2002. To kill or be killed: viral
evasion of apoptosis. Nat. Immunol. 3:1013–1018.
4. Boya, P., B. Roques, and G. Kroemer. 2001. Viral and bacterial proteins
regulating apoptosis at the mitochondrial level. EMBO J. 20:4325–4331.
5. Brown, T. D. K., and I. Brierly. 1995. The coronavirus nonstructural pro-
teins, p. 191–217. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press,
New York, N.Y.
6. Chau, T. N., K. C. Lee, H. Yao, T. Y. Tsang, T. C. Chow, Y. C. Yeung, K. W.
Choi, Y. K. Tso, T. Lau, S. T. Lai, and C. L. Lai. 2004. SARS-associated viral
hepatitis caused by a novel coronavirus: report of three cases. Hepatology
39:302–310.
7. Collins, A. R. 2002. In vitro detection of apoptosis in monocytes/macro-
phages infected with human coronavirus. Clin. Diagn. Lab. Immunol.
9:1392–1395.
8. Drosten, C., S. Gunther, W. Preiser, S. van der Werf, H. R. Brodt, S. Becker,
H. Rabenau, M. Panning, L. Kolesnikova, R. A. Fouchier, A. Berger, A. M.
Burguiere, J. Cinatl, M. Eickmann, N. Escriou, K. Grywna, S. Kramme, J. C.
Manuguerra, S. Muller, V. Rickerts, M. Sturmer, S. Vieth, H. D. Klenk, A. D.
Osterhaus, H. Schmitz, and H. W. Doerr. 2003. Identification of a novel
coronavirus in patients with severe acute respiratory syndrome. N. Engl.
J. Med. 348:1967–1976.
9. Eleouet, J. F., S. Chilmonczyk, L. Besnardeau, and H. Laude. 1998. Trans-
missible gastroenteritis coronavirus induces programmed cell death in in-
fected cells through a caspase-dependent pathway. J. Virol. 72:4918–4924.
10. Everett, H., and G. McFadden. 1999. Apoptosis: an innate immune response
to virus infection. Trends Microbiol. 7:160–165.
11. Fielding, B. C., Y.-J. Tan, S. Shen, T. H. P. Tan, E.-E. Ooi, S. G., Lim, W.
Hong, and P.-Y. Goh. 2004. Characterization of a unique group-specific
protein (U122) of the severe acute respiratory syndrome coronavirus. J. Vi-
rol. 78:7311–7318.
12. Fouchier, R. A., T. Kuiken, M. Schutten, G. van Amerongen, G. J. van
Doornum, B. G. van den Hoogen, M. Peiris, W. Lim, K. Stohr, and A. D.
Osterhaus. 2003. Aetiology: Koch’s postulates fulfilled for SARS virus. Na-
ture 423:240.
12a.Guan, M., H. Y. Chen, P. H. Tan, S. Shen, P.-Y. Goh, Y.-J. Tan, P. H. Pang,
Y. Lu, P. Y. Fong, and D. Chin. 2004. Use of viral lysate antigen combined
with recombinant protein in Western immunoblot assay as a confirmatory
test for serodiagnosis of severe acute respiratory syndrome. Clin. Diagn. Lab.
Immunol. 11:1148–1153.
13. Haagmans, B. L., H. F. Egberink, and M. C. Horzinek. 1996. Apoptosis and
T-cell depletion during feline infectious peritonitis. J. Virol. 70:8977–8983.
14. Hay, S., and G. Kannourakis. 2002. A time to kill: viral manipulation of the
cell death program. J. Gen. Virol. 83:1547–1564.
15. Humar, A., I. McGilvray, M. J. Phillips, and G. A. Levy. 2004. Severe acute
respiratory syndrome and the liver. Hepatology 39:291–294.
16. Ksiazek, T. G., D. Erdman, C. S. Goldsmith, S. R. Zaki, T. Peret, S. Emery,
S. Tong, C. Urbani, J. A. Comer, W. Lim, P. E. Rollin, S. F. Dowell, A. E.
Ling, C. D. Humphrey, W. J. Shieh, J. Guarner, C. D. Paddock, P. Rota, B.
Fields, J. DeRisi, J. Y. Yang, N. Cox, J. M. Hughes, J. W. LeDuc, W. J.
Bellini, L. J. Anderson, and the SARS Working Group. 2003. A novel
coronavirus associated with severe acute respiratory syndrome. N. Engl.
J. Med. 348:1953–1966.
17. Lai, M. M. C., and D. Cavanagh. 1997. The molecular biology of coronavi-
ruses. Adv. Virus Res. 48:1–100.
18. Liu, C., H. Y. Xu, and D. X. Liu. 2001. Induction of caspase-dependent
apoptosis in cultured cells by the avian coronavirus infectious bronchitis
virus. J. Virol. 75:6402–6409.
19. Marra, M. A., S. J. Jones, C. R. Astell, R. A. Holt, A. Brooks-Wilson, Y. S.
Butterfield, J. Khattra, J. K. Asano, S. A. Barber, S. Y. Chan, A. Cloutier,
S. M. Coughlin, D. Freeman, N. Girn, O. L. Griffith, S. R. Leach, M. Mayo,
H. McDonald, S. B. Montgomery, P. K. Pandoh, A. S. Petrescu, A. G.
Robertson, J. E. Schein, A. Siddiqui, D. E. Smailus, J. M. Stott, G. S. Yang,
F. Plummer, A. Andonov, H. Artsob, N. Bastien, K. Bernard, T. F. Booth, D.
Bowness, M. Czub, M. Drebot, L. Fernando, R. Flick, M. Garbutt, M. Gray,
A. Grolla, S. Jones, H. Feldmann, A. Meyers, A. Kabani, Y. Li, S. Normand,
U. Stroher, G. A. Tipples, S. Tyler, R. Vogrig, D. Ward, B. Watson, R. C.
Brunham, M. Krajden, M. Petric, D. M. Skowronski, C. Upton, and R. L.
Roper. 2003. The genome sequence of the SARS-associated coronavirus.
Science 300:1399–1404.
20. Nishioka, W. K., and R. M. Welsh. 1993. B cells induce apoptosis via a novel
mechanism in fibroblasts infected with mouse hepatitis virus. Nat. Immunol.
12:113–127.
21. O’Donnell, R., R. C. Tasker, and M. F. Roe. 2003. SARS: understanding the
coronavirus: apoptosis may explain lymphopenia of SARS. BMJ 327:620.
22. Panesar, N. S. 2003. Lymphopenia in SARS. Lancet 361:1985.
23. Peiris, J. S., K. Y. Yuen, A. D. Osterhaus, and K. Stohr. 2003. The severe
acute respiratory syndrome. N. Engl. J. Med. 349:2431–2441.
24. Peiris, J. S., S. T. Lai, L. L. Poon, Y. Guan, L. Y. Yam, W. Lim, J. Nicholls,
W. K. Yee, W. W. Yan, M. T. Cheung, V. C. Cheng, K. H. Chan, D. N. Tsang,
R. W. Yung, T. K. Ng, and K. Y. Yuen, and the SARS Study Group. 2003.
Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet
361:1319–1325.
25. Rota, P. A., M. S. Oberste, S. S. Monroe, W. A. Nix, R. Campagnoli, J. P.
Icenogle, S. Penaranda, B. Bankamp, K. Maher, M. H. Chen, S. Tong, A.
Tamin, L. Lowe, M. Frace, J. L. DeRisi, Q. Chen, D. Wang, D. D. Erdman,
T. C. Peret, C. Burns, T. G. Ksiazek, P. E. Rollin, A. Sanchez, S. Liffick, B.
Holloway, J. Limor, K. McCaustland, M. Olsen-Rasmussen, R. Fouchier, S.
Gunther, A. D. Osterhaus, C. Drosten, M. A. Pallansch, L. J. Anderson, and
W. J. Bellini. 2003. Characterization of a novel coronavirus associated with
severe acute respiratory syndrome. Science 300:1394–1399.
26. Roulston, A., R. C. Marcellus, and P. E. Branton. 1999. Viruses and apo-
ptosis. Annu. Rev. Microbiol. 53:577–628.
27. Tan, Y. J., P.-Y. Goh, B. C. Fielding, S. Shen, C.-F. Chou, J.-L. Fu, H. N.
Leong, Y. S. Leo, E. E. Ooi, A. E. Ling, S. G. Lim, and W. Hong. 2004. Profile
of antibody responses against SARS coronavirus recombinant proteins and
their potential use as diagnostic markers. Clin. Diagn. Lab. Immunol. 11:
362–371.
28. Tan, Y.-J., E. Teng, S. Shen, T. H. P. Tan, P.-Y. Goh, B. C. Fielding, E.-E.
Ooi, H.-C. Tan, S. G. Lim, and W. Hong. 2004. A novel SARS coronavirus
protein, U274, is transported to the cell surface and undergoes endocytosis.
J. Virol. 78:6723–6734.
29. Thiel, V., K. A. Ivanov, A. Putics, T. Hertzig, B. Schelle, S. Bayer, B. Weiss-
brich, E. J. Snijder, H. Rabenau, H. W. Doerr, A. E. Gorbalenya, and J.
Ziebuhr. 2003. Mechanisms and enzymes involved in SARS coronavirus
genome expression. J. Gen. Virol. 84:2305–2315.
30. Thomson, B. J. 2001. Viruses and apoptosis. Int. J. Exp. Pathol. 82:65–76.
31. Yan, H., G. Xiao, J. Zhang, Y. Hu, F. Yuan, D. K. Cole, C. Zheng, and G. F.
Gao. 2004. SARS coronavirus induces apoptosis in Vero E6 cells. J. Med.
Virol. 73:323–331.
32. Zhang, Q. L., Y. Q. Ding, L. He, W. Wang, J. H. Zhang, H. J. Wang, J. J. Cai,
J. Geng, Y. D. Lu, and Y. L. Luo. 2003. Detection of cell apoptosis in the
pathological tissues of patients with SARS and its significance. Di Yi Jun Yi
Da Xue Xue Bao 23:770–773.
VOL. 78, 2004 NOTES 14047
